long term effects of semaglutide GLP-1 Vs Zepbound For Weight Loss New Side Effects of Semaglutide

CrossRef Stubbs B, Vancampfort D, Veronese N, et al

Why this trial matters: First large Phase III evidence of biopsy-confirmed histologic benefit with a metabolic drug in MASH Demonstrates semaglutides impact beyond weight loss to disease-modifying liver effects Supports expanding GLP-1 therapeutics into liver disease care amid a high unmet need Ianalumab Meets Endpoints in Phase III Sjgrens Disease Trials (NEPTUNUS-1 & 2) Novartis reported that both Phase III studies of ianalumab achieved their primary endpoints in patients with Sjgrens disease, offering the first targeted therapy with statistically significant disease activity reduction in this chronic autoimmune disorder

However, long-term drug treatment can lead to a series of side effects, limiting their therapeutic effectiveness

traditional machine resistance training protocols using small muscle group exercises FASEB J doi: 10.1096/fj.202100242R

This 8-10 percentage point difference is clinically meaningful and represents the difference between good and excellent weight loss outcomes

Stop immediately if you experience Severe burning or stinging that doesn't fade within minutes